UPC Analytics
ENDE
Overview · Filed: Mar 3, 2025

UPC_CFI_191/2025

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

InfringementMain Infringement ActionThe Hague LDInfringementInterim Phase
Parties

Claimants

  • Genevant Sciences GmbH
  • Arbutus Biopharma Corporation
Reps:

Respondents

Reps:
Judges
  • Edger Brinkman
  • Margot Kokke
  • Samuel Granata
  • Xavier Dorland-Galliot
Patents
  • EP2279254
CPC codes: C07J9/00, A61P31/14, A61K9/1271, C12N15/111, C12N2310/14, C12N15/113, A61K9/1272, A61P35/00, A61K31/713, C12N2320/32, A61P31/12, C12N15/1137

Technology area: Biotech · mRNA

Sector: Biotechnology

Outcome
Procedural onlyProcedural only (no substantive ruling yet)
Filed: Mar 3, 2025
First decided:
Language: English
Open on UPC Registry